Advertisement

Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High

Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High

Teva stock surged Wednesday after the company beat first-quarter views and unveiled promising results from its schizophrenia drug study.